JY
RCKTW icon

Jeff Yass’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Jeff Yass’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,692
Closed -$1.72K – 13388
2025
Q3 		$1.72K Buy
47,692
+5,133
+12% +$200 ﹤0.01% 12179
2025
Q2 		$1.68K Sell
42,559
-77,412
-65% -$3.22K ﹤0.01% 12495
2025
Q1 		$5.64K Buy
+119,971
New +$7.8K ﹤0.01% 12253
2024
Q4 		– Sell
-90,947
Closed -$6.37K – 13033
2024
Q3 		$6.37K Sell
90,947
-79,417
-47% -$6.12K ﹤0.01% 11745
2024
Q2 		$10.3K Buy
+170,364
New +$19.4K ﹤0.01% 11774

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Jeff Yass's RCKTW Position: Q4 2025 in Review

Jeff Yass sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q4 2025, closing a stake of 47,692 shares — an estimated $1.72K sold.

Jeff Yass first reported a position in RCKTW in Q2 2024 and held it in 5 quarters. The position peaked at $10.3K in Q2 2024. 12 funds tracked by Wall St. Rank hold RCKTW as of Q4 2025.

  • Jeff Yass reported no remaining Rocket Pharmaceuticals Warrant position as of Q4 2025 after selling out during the quarter.
  • Jeff Yass sold 47,692 Rocket Pharmaceuticals Warrant shares in Q4 2025, an estimated $1.72K.
  • Jeff Yass first reported a position in Rocket Pharmaceuticals Warrant in Q2 2024 and held it in 5 quarters.
  • Jeff Yass's Rocket Pharmaceuticals Warrant position peaked at $10.3K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.